» Articles » PMID: 22024949

Effects of a 12-month Physical Activity Intervention on Prevalence of Metabolic Syndrome in Elderly Men and Women

Overview
Specialty Geriatrics
Date 2011 Oct 26
PMID 22024949
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Background: There is a lack of information on whether exercise training alone can reduce the prevalence of metabolic syndrome (MetS) in elderly men and women.

Methods: This study was an ancillary to the Lifestyle Interventions and Independence for Elders Pilot Study, a four-site, single-blind, randomized controlled clinical trial comparing a 12-month physical activity (PA) intervention (N = 180) with a successful aging intervention (N = 181) in elderly (70-89 years) community-dwelling men and women at risk for physical disability. The PA intervention included aerobic, strength, and flexibility exercises, with walking as the primary mode. MetS was defined using the National Cholesterol Education Program criteria.

Results: There was no significant change in body weight or fat mass after either intervention. The trend of MetS prevalence over the intervention period was similar between PA and successful aging groups (p = .77). Overall, the prevalence of MetS decreased significantly from baseline to 6 months (p = .003) but did not change further from 6- to 12-month visits (p = .11). There were no group differences in any individual MetS components (p > .05 for all group by visit interactions). However, in individuals not using medications at any visit to treat MetS components, those in the PA intervention had lower odds of having MetS than those in the successful aging group during follow-up (odds ratio = 0.28, 95% confidence interval = 0.08-0.96).

Conclusions: In this sample, a 12-month PA intervention did not reduce the prevalence of MetS more than a successful aging intervention, perhaps due to the large proportion of individuals taking medications for treating MetS components.

Citing Articles

Tailored Exercise Intervention in Metabolic Syndrome: Cardiometabolic Improvements Beyond Weight Loss and Diet-A Prospective Observational Study.

Braggio M, Dorelli G, Olivato N, Lamberti V, Valenti M, Dalle Carbonare L Nutrients. 2025; 17(5).

PMID: 40077741 PMC: 11901541. DOI: 10.3390/nu17050872.


Efficacy of a multidimensional self-management intervention on low-education women with metabolic syndrome: a cluster randomized controlled trial.

Chang S, Chang Y, Jeng W, Wai J Sci Rep. 2023; 13(1):10358.

PMID: 37365208 PMC: 10293226. DOI: 10.1038/s41598-023-36971-y.


Effect of a Community Gerontology Program on the Control of Metabolic Syndrome in Mexican Older Adults.

Mendoza-Nunez V, Pulido-Castillo G, Correa-Munoz E, Rosado-Perez J Healthcare (Basel). 2022; 10(3).

PMID: 35326944 PMC: 8950718. DOI: 10.3390/healthcare10030466.


Walking for hypertension.

Lee L, Mulvaney C, Wong Y, Chan E, Watson M, Lin H Cochrane Database Syst Rev. 2021; 2:CD008823.

PMID: 33630309 PMC: 8128358. DOI: 10.1002/14651858.CD008823.pub2.


The Effect of Exercise on the Older Adult's Blood Pressure Suffering Hypertension: Systematic Review and Meta-Analysis on Clinical Trial Studies.

Kazeminia M, Daneshkhah A, Jalali R, Vaisi-Raygani A, Salari N, Mohammadi M Int J Hypertens. 2020; 2020:2786120.

PMID: 33014449 PMC: 7512073. DOI: 10.1155/2020/2786120.


References
1.
Carroll S, Dudfield M . What is the relationship between exercise and metabolic abnormalities? A review of the metabolic syndrome. Sports Med. 2004; 34(6):371-418. DOI: 10.2165/00007256-200434060-00004. View

2.
Malik S, Wong N, Franklin S, Kamath T, LItalien G, Pio J . Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation. 2004; 110(10):1245-50. DOI: 10.1161/01.CIR.0000140677.20606.0E. View

3.
Johnson J, Slentz C, Houmard J, Samsa G, Duscha B, Aiken L . Exercise training amount and intensity effects on metabolic syndrome (from Studies of a Targeted Risk Reduction Intervention through Defined Exercise). Am J Cardiol. 2007; 100(12):1759-66. PMC: 2190779. DOI: 10.1016/j.amjcard.2007.07.027. View

4.
Arnlov J, Ingelsson E, Sundstrom J, Lind L . Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men. Circulation. 2009; 121(2):230-6. DOI: 10.1161/CIRCULATIONAHA.109.887521. View

5.
Ford E . Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. Diabetes Care. 2005; 28(11):2745-9. DOI: 10.2337/diacare.28.11.2745. View